Cortactin (from "corticalactin binding protein") is a monomericprotein located in thecytoplasm of cells that can be activated by external stimuli to promotepolymerization and rearrangement of theactincytoskeleton, especially the actin cortex around the cellular periphery.[5][6] It is present in all cell types. When activated, it will recruitArp2/3 complex proteins to existing actin microfilaments, facilitating and stabilizingnucleation sites for actin branching. Cortactin is important in promotinglamellipodia formation,invadopodia formation,cell migration, andendocytosis.
Cortactin is a thin, elongatedmonomer that consists of an amino-terminal acidic (NTA) region; 37-residue-long segments that are highly conserved among cortactin proteins of all species and repeated up to 6.5 times in tandem (“cortactin repeats”); a proline-rich region; and anSH3 domain. This basic structure is highly conserved among all species that express cortactin.[8]
TheSH3 domain of certain tyrosine kinases, such as the oncogeneSrc kinase, binds to cortactin's proline-rich region and phosphorylates it on Tyr421, Tyr466, and Tyr482. Once activated in this way, it can bind tofilamentous actin (F-actin) with the fourth of its cortactin repeats.[8] As the concentration of phosphorylated cortactin increases in specific regions within the cell, the monomers each begin to recruit an Arp2/3 complex to F-actin. It binds to Arp2/3 with an aspartic acid-aspartic acid-tryptophan (DDW) sequence in its NTA region, a motif that is often seen in other actinnucleation-promoting factors (NPFs).[9]
Certain serine/threonine kinases, such asERK, can phosphorylate cortactin on Ser405 and Ser418 in the SH3 domain.[8] Activated like this, it still associates with Arp2/3 and F-actin, but will also allow other actin NPFs, most importantly N-WASp (NeuronalWiskott-Aldrich syndrome protein), to bind to the complex as well; when phosphorylated by tyrosine kinases, other NPFs are excluded.[10] The ability of these other NPFs to bind the Arp2/3 complex while cortactin is also bound could come from new interactions with cortactin's SH3 domain, which is in a different conformation when phosphorylated by Ser/Thr kinases and thus may be more open to interactions with other NPFs.[10] Having other NPFs bind to the Arp2/3 complex at the same time as cortactin may enhance nucleation site stability.[8]
Inactive cortactin diffuses throughout the cytoplasm, but upon phosphorylation, the protein begins to target certain areas in the cell. Cortactin-assisted Arp2/3-nucleated actin branches are most prominent in the actin cortex, around the periphery of the cell.[11] A phosphorylated cortactin monomer binds to, activates, and stabilizes an Arp2/3 complex on preexisting F-actin, which provides a nucleation site for a new actin branch to form from the “mother” filament. Branches formed from cortactin-assisted nucleation sites are very stable; cortactin has been shown to inhibit debranching.[11] Thus, polymerization and branching of actin is promoted in areas of the cell where cortactin is localized.
Cortactin is very active in lamellipodia, protrusions of the cell membrane formed by actin polymerization andtreadmilling that propel the cell along a surface as it migrates towards some target.[12]
Cortactin acts as a link between extracellular signals and lamellipodial “steering.” When areceptor tyrosine kinase on thecell membrane binds to an adhesion site, for example, cortactin will be phosphorylated locally to the area of binding, activate and recruit Arp2/3 to the actin cortex in that region, and thus stimulate cortical actin polymerization and movement of the cell in that direction.Macrophages, highly motile immune cells that engulf cellular debris andpathogens, are propelled by lamellipodia and identify/migrate toward a target viachemotaxis; thus, cortactin must also be activated by receptor kinases that pick up a large variety of chemical signals.[12]
Studies have implicated cortactin in bothclathrin-mediated endocytosis[13] and clathrin-independent endocytosis.[14] In both kinds of endocytosis, it has long been known that actin localizes to sites of vesicle invagination and is a vital part of the endocytic pathway, but the actual mechanisms by which actin facilitates endocytosis are still unclear. Recently, however, it has been found thatdynamin, the protein responsible for breaking the newly formed vesicular bud off the inside of theplasma membrane, can associate with the SH3 domain of cortactin. Since cortactin recruits the Arp2/3 complexes that lead to actin polymerization, this suggests that it may play an important part in linking vesicle formation to the as yet unknown functions actin has in endocytosis.[15]
Amplification of the genes encoding cortactin—in humans, EMS1—has been found to occur in certaintumors. Overexpression of cortactin can lead to highly-active lamellipodia in tumor cells, dubbed “invadopodia.” These cells are especiallyinvasive and migratory, making them very dangerous, for they can easily spread cancer across the body into other tissues.[16]
^Brookes S, Lammie GA, Schuuring E, de Boer C, Michalides R, Dickson C, Peters G (April 1993). "Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3, including the expressed gene EMS1".Genes Chromosomes Cancer.6 (4):222–31.doi:10.1002/gcc.2870060406.PMID7685625.S2CID36282099.
^Di Ciano C, Nie Z, Szászi K, Lewis A, Uruno T, Zhan X, Rotstein OD, Mak A, Kapus A (September 2002). "Osmotic stress-induced remodeling of the cortical cytoskeleton".Am. J. Physiol., Cell Physiol.283 (3): C850-65.doi:10.1152/ajpcell.00018.2002.PMID12176742.
^Mizutani K, Miki H, He H, Maruta H, Takenawa T (February 2002). "Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts".Cancer Res.62 (3):669–74.PMID11830518.
Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ (1992). "Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas".Oncogene.7 (2):355–61.PMID1532244.
Brookes S, Lammie GA, Schuuring E, de Boer C, Michalides R, Dickson C, Peters G (1993). "Amplified region of chromosome band 11q13 in breast and squamous cell carcinomas encompasses three CpG islands telomeric of FGF3, including the expressed gene EMS1".Genes Chromosomes Cancer.6 (4):222–31.doi:10.1002/gcc.2870060406.PMID7685625.S2CID36282099.
Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides".Gene.138 (1–2):171–4.doi:10.1016/0378-1119(94)90802-8.PMID8125298.
Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library".Gene.200 (1–2):149–56.doi:10.1016/S0378-1119(97)00411-3.PMID9373149.
